Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2010
09/21/2010CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2434178C Substituted amine derivatives and methods of use
09/21/2010CA2428019C Estrogen receptor modulators
09/21/2010CA2408746C Antisense phosporodiamidate morpholino oligonucleotide inhibition of cytochrome p450 to modulate drug pharmacokinetics
09/21/2010CA2359948C Triazole compounds with dopamine-d3-receptor affinity
09/21/2010CA2309356C Novel exendin agonist compounds
09/21/2010CA2307142C N-terminally chemically modified protein compositions and methods
09/21/2010CA2306692C Dipeptide apoptosis inhibitors and the use thereof
09/21/2010CA2225675C Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits
09/16/2010WO2010105253A2 Methods and compositions for treating complications of diabetes and vascular diseases using flavones
09/16/2010WO2010105048A1 Thiazolidinedione analogues
09/16/2010WO2010104830A1 Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists
09/16/2010WO2010104721A1 Mineralocorticoid receptor antagonist and methods of use
09/16/2010WO2010104384A1 Nutritional composition inducing a postprandial endocrine response
09/16/2010WO2010104374A1 Nutritional composition inducing a postprandial endocrine response
09/16/2010WO2010104205A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010WO2010104195A1 Novel isoindolin-1-one derivative
09/16/2010WO2010104024A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010WO2010104023A1 Infusion solution for administration to peripheral vein comprising carbohydrate solution having vitamin b1 contained therein stably
09/16/2010WO2010103837A1 Progression inhibitor or prophylactic agent for atherosclerosis, blood cholesterol level-lowering agent, and functional food or food for specified health uses
09/16/2010WO2010103437A1 Benzofuranyl derivatives used as glucokinase inhibitors
09/16/2010WO2010103335A1 Compounds for the treatment of metabolic disorders
09/16/2010WO2010103334A1 Compounds for the treatment of metabolic disorders
09/16/2010WO2010103333A1 Compounds for the treatment of metabolic disorders
09/16/2010WO2010103320A1 Use of rosuvastatin lactols as medicaments
09/16/2010WO2010103319A1 Use of atorvastatin lactols as medicaments
09/16/2010WO2010103318A1 Rosuvastatin and atorvastatin derivatives
09/16/2010WO2010103045A1 Treatment of diabetes and metabolic syndrome
09/16/2010WO2010102972A1 Plasma-adapted full electrolyte solution
09/16/2010WO2010102512A1 C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof
09/16/2010WO2010102508A1 Preparation method of carotenoid oil suspensions with low viscosity and high fluidity and its use
09/16/2010WO2010065889A3 Cyclobutanemethanamine inhibitors of monomine reuptake
09/16/2010WO2010059606A3 Inhibitors of diacylglycerol acyltransferase
09/16/2010WO2010056910A3 Methods of treating cardiovascular disorders
09/16/2010WO2010052563A3 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
09/16/2010US20100235935 Plasma anti-diabetic nucb2 peptide (pladin) and uses thereof
09/16/2010US20100234599 Method for preparing acid addition salts of polyacidic basic compounds
09/16/2010US20100234466 Compositions and Methods for Reducing Body Fat
09/16/2010US20100234464 Compounds for the treatment of metabolic disorders
09/16/2010US20100234452 Anti-Inflammatory and Antioxidant Conjugates Useful for Treating Metabolic Disorders
09/16/2010US20100234448 In vivo production of small interfering rnas that mediate gene silencing
09/16/2010US20100234447 Modulation of glucagon receptor expression
09/16/2010US20100234443 Combinations of statins and anti-obesity agent
09/16/2010US20100234439 Therapeutic agents
09/16/2010US20100234438 Therapeutic agents
09/16/2010US20100234433 Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
09/16/2010US20100234431 Pyrrolidine compounds
09/16/2010US20100234403 Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
09/16/2010US20100234392 4-sulfonylpiperidine derivatives
09/16/2010US20100234387 Sulfonylated Tetrahydroazolopyrazines and their Use as Pharmaceuticals
09/16/2010US20100234385 Compsition Containing Biopterin and Method for Using The Same
09/16/2010US20100234377 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
09/16/2010US20100234374 Heterocycle Substituted Ketone Derivatives as Histone Deacetylase (HDAC) Inhibitors
09/16/2010US20100234373 Bis-aryl amide compounds and methods of use
09/16/2010US20100234370 Pharmaceutical compounds
09/16/2010US20100234367 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010US20100234366 Use of Strobilurins for the Treatment of Disorders of Iron Metabolism
09/16/2010US20100234365 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
09/16/2010US20100234363 Heterocyclic derivative having inhibitory activity on type-i 11 data-hydroxysteroid dehydrogenase
09/16/2010US20100234362 Use of diazoxide for suppressing the plasma insulin level in a mammal
09/16/2010US20100234356 Compounds useful as chemokine receptor antagonists
09/16/2010US20100234346 Novel pyrimidine derivatives
09/16/2010US20100234344 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
09/16/2010US20100234341 Substituted pyrimidines as adenosine receptor antagonists
09/16/2010US20100234340 Substituted Spiroamide Compounds
09/16/2010US20100234335 Neurosteroid compounds
09/16/2010US20100234334 Nitric oxide releasing steroids
09/16/2010US20100234331 Hexahydro-cyclooctyl pyrazole cannabinoid modulators
09/16/2010US20100234317 Use of difructose anhydride-containing composition
09/16/2010US20100234307 Preparation and use of biphenyl amino acid derivatives for the treatment of obesity
09/16/2010US20100234306 Use of a peptide as a therapeutic agent
09/16/2010US20100234299 Stable formulation of modified glp-1
09/16/2010US20100234297 Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
09/16/2010US20100234290 Stabilized Insulin-like Growth Factor Polypeptides
09/16/2010US20100234285 Benzofuranyl Derivatives
09/16/2010US20100234279 Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
09/16/2010US20100233810 In vivo production of small interfering rnas that mediate gene silencing
09/16/2010US20100233735 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
09/16/2010US20100233722 Methods for determining the biological effect and/or activity of r pharmaceutical compositions based on their effect on the methylation status of the DNA
09/16/2010US20100233306 Methods and compositions for weight loss using garcinia indica fruit puree
09/16/2010US20100233290 Use of difructose anhydride-containing composition
09/16/2010US20100233281 Process for decreasing environmental pollutants in an oil or a fat.
09/16/2010US20100233274 Means and methods for enhancing weight gain in poultry
09/16/2010US20100233255 Combination of trazine derivatives and insulin secretion stimulators
09/16/2010US20100233226 Drug-eluting nanowire array
09/16/2010US20100233216 Use of microvesicles (mvs) for preparing a medicament having adjuvant activity on endothelial cell transplantation, particularly in the treatment of diabetes by pancreatic islet transplantation, and related method
09/16/2010US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides
09/16/2010US20100233162 LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS
09/16/2010US20100233157 Human antibodies against human fas and their use
09/16/2010US20100233143 Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells
09/16/2010US20100233116 Organic compounds
09/16/2010CA2755120A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010CA2755117A1 Substituted fused pyrimidine compounds
09/16/2010CA2755068A1 Treatment of diabetes and metabolic syndrome
09/16/2010CA2754825A1 Use of rosuvastatin lactols as medicaments
09/16/2010CA2754794A1 Compounds for the treatment of metabolic disorders
09/16/2010CA2754791A1 Compounds for the treatment of metabolic disorders
09/16/2010CA2754787A1 Use of atorvastatin lactols as medicaments
09/16/2010CA2754709A1 Compounds for the treatment of metabolic disorders
1 ... 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 ... 1298